Next report date
Report period
Q1 2024
EPS estimate
0.00EUR
Revenue estimate
467.10 MEUR
0.0035EUR
162.94 MEUR
1.79 BEUR
18.72 B
About KALBE FARMA
Sector
CEO
Vidjongtius
Headquarters
Jakarta
Website
Employees (FY)
13.11 K
Founded
1966
ISIN
ID1000125107
FIGI
BBG000BXWDV6
PT Kalbe Farma Tbk is engaged in the development, distribution, and trading of pharmaceutical products. It operates through the following divisions: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The Prescription Pharmaceutical division offers generic drugs, branded generics, and licensed drugs, which are distributed to hospitals, pharmacies, and drug stores. The Consumer Health division includes over-the-counter drugs, consumer products, food supplements, preventive products, energy drinks, and healthy ready-to-drink products. The Nutritionals division sells biscuits, cereals, and milk products for infants, toddlers, children, pre-teenagers, adults, expectant and lactating mothers, and elderly; as well as nutritional products for consumers with special medical needs. The Distribution and Logistic division maintains distribution of the company's and third party principal's products across Indonesia; and focuses on the trading of raw material, medical devices, and retail health service. The company founded by Boenyamin Setiawan on September 10, 1966 and is headquartered in Jakarta, Indonesia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange PT KALBE FARMA TBK. stocks are traded under the ticker LCLA.
PT KALBE FARMA TBK. is going to release the next earnings report on Apr 29, 2024. Keep track of upcoming events with our Earnings Calendar.
LCLA earnings for the last quarter are 0.00 EUR per share, whereas the estimation was 0.00 EUR resulting in a −36.08% surprise. The estimated earnings for the next quarter are 0.00 EUR per share. See more details about PT KALBE FARMA TBK. earnings.
PT KALBE FARMA TBK. revenue for the last quarter amounts to 453.92 M EUR despite the estimated figure of 476.42 M EUR. In the next quarter revenue is expected to reach 462.92 M EUR.
Yes, you can track PT KALBE FARMA TBK. financials in yearly and quarterly reports right on TradingView.
LCLA net income for the last quarter is 41.33 M EUR, while the quarter before that showed 32.95 M EUR of net income which accounts for 25.42% change. Track more PT KALBE FARMA TBK. financial stats to get the full picture.
Yes, LCLA dividends are paid annually. The last dividend per share was 0.00 EUR. As of today, Dividend Yield (TTM)% is 2.70%. Tracking PT KALBE FARMA TBK. dividends might help you take more informed decisions.
Like other stocks, LCLA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PT KALBE FARMA TBK. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 13.11 K employees. See our rating of the largest employees — is PT KALBE FARMA TBK. on this list?
We've gathered analysts' opinions on PT KALBE FARMA TBK. future price: according to them, LCLA price has a max estimate of 0.11 EUR and a min estimate of 0.09 EUR. Read a more detailed PT KALBE FARMA TBK. forecast: see what analysts think of PT KALBE FARMA TBK. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PT KALBE FARMA TBK. EBITDA is 254.67 M EUR, and current EBITDA margin is 14.20%. See more stats in PT KALBE FARMA TBK. financial statements.